197 related articles for article (PubMed ID: 24251712)
1. Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis.
Hino K; Nishina S; Hara Y
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():93-8. PubMed ID: 24251712
[TBL] [Abstract][Full Text] [Related]
2. Iron metabolic disorder in chronic hepatitis C: insights from recent evidence.
Hino K; Nishina S; Hara Y
Clin J Gastroenterol; 2012 Aug; 5(4):251-6. PubMed ID: 26182389
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
Hino K; Nishina S; Sasaki K; Hara Y
Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
6. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
7. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.
Choi J; Ou JH
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G847-51. PubMed ID: 16603728
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.
Foka P; Dimitriadis A; Karamichali E; Kyratzopoulou E; Giannimaras D; Koskinas J; Varaklioti A; Mamalaki A; Georgopoulou U
Virulence; 2016 Aug; 7(6):679-90. PubMed ID: 27058404
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
12. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
13. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.
Tanaka H; Fujita N; Sugimoto R; Urawa N; Horiike S; Kobayashi Y; Iwasa M; Ma N; Kawanishi S; Watanabe S; Kaito M; Takei Y
Br J Cancer; 2008 Feb; 98(3):580-6. PubMed ID: 18231107
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
15. Elevated hepatic iron: a confounding factor in chronic hepatitis C.
Isom HC; McDevitt EI; Moon MS
Biochim Biophys Acta; 2009 Jul; 1790(7):650-62. PubMed ID: 19393721
[TBL] [Abstract][Full Text] [Related]
16. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.
Moriya K; Nakagawa K; Santa T; Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Miyazawa T; Ishibashi K; Horie T; Imai K; Todoroki T; Kimura S; Koike K
Cancer Res; 2001 Jun; 61(11):4365-70. PubMed ID: 11389061
[TBL] [Abstract][Full Text] [Related]
18. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
Hörl WH; Schmidt A
Nephrol Dial Transplant; 2014 Jun; 29(6):1141-4. PubMed ID: 24286977
[TBL] [Abstract][Full Text] [Related]
19. [A study on hepatic iron overload in chronic hepatitis C patients].
Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
[TBL] [Abstract][Full Text] [Related]
20. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
Lecube A; Hernández C; Simó R
Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
